Ali Gharavi, MD (Co-PI, Columbia University U54 O’Brien Center) discusses opportunities for genomic medicine in benign urology; Eli Broemer, graduate student (Michigan State Univ; Beaumont-Oakland Univ P20 Center) discusses what 3D reconstruction during ex vivo filling can teach us about bladder biomechanics; Mendelsohn, PhD (Co-PI, Columbia University U54 O’Brien Center) discusses transcriptional control of urothelial specification in homeostasis and regeneration; and Michael Odom, PhD (K12 Scholar, Duke University KURe Program) discusses detrusor contractility via FP receptor activation is increased in diabetic mice with bladder underactivity at the 2022 Annual CAIRIBU* Meeting.
*Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) is an umbrella organization that brings together NIDDK-funded investigators devoted exclusively to investigating benign genitourinary diseases and disorders. A primary objective of CAIRIBU is to encourage interdisciplinary interactions and build effective research collaborations that can tackle the most critical questions related to benign prostatic hyperplasia, urolithiasis, bladder disorders, urinary tract infection, pelvic pain, and genitourinary developmental disorders. Visit the CAIRIBU Community website here: https://cairibu.urology.wisc.edu/.
source
